Advertisement

Topics

Marinomed Biotech AG (MARI-AT): 2019E off to a -2-

17:45 EDT 9 May 2019 | FinanzNachrichten

DJ Marinomed Biotech AG (MARI-AT): 2019E off to a good start. All eyes on Budesolv. Dow Jones received a payment from EQS/DGAP to publish this press release. goetzpartners securities Limited Marin...

Original Article: Marinomed Biotech AG (MARI-AT): 2019E off to a -2-

NEXT ARTICLE

More From BioPortfolio on "Marinomed Biotech AG (MARI-AT): 2019E off to a -2-"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Ophthalmology
Ophthalmology is the branch of medicine that is devoted to the study and treatment of eye diseases. As well as mild visual defects correctable by lenses, ophthalmology is concerned with glaucoma, uveitis and other serious conditions affecting the eye, ...